July 5, 2024 – Federal Register Recent Federal Regulation Documents

Determination of Regulatory Review Period for Purposes of Patent Extension; Imjudo
Document Number: 2024-14716
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for IMJUDO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
South Texas Project Nuclear Operating Company; South Texas Project Electric Generating Station, Units 1 and 2; Independent Spent Fuel Storage Installation; Exemption
Document Number: 2024-14715
Type: Notice
Date: 2024-07-05
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission (NRC) issued an exemption to South Texas Project Nuclear Operating Company permitting South Texas Project Electric Generating Station to shuffle (relocate) 10 already loaded model 37 multi-purpose canisters (MPC) with continuous basket shims (MPC-37-CBS) in January 2025 and to load two new MPC-37-CBS in the HI-STORM Flood/Wind MPC Storage System at its South Texas Project Electric Generating Station, Units 1 and 2 independent spent fuel storage installation in a storage condition where the terms, conditions, and specifications in the Certificate of Compliance No. 1032, Amendment No. 2, are not met.
Authorization of Emergency Use of Monkeypox Polymerase Chain Reaction Test Home Collection Kit in Response to an Outbreak of Mpox; Availability
Document Number: 2024-14714
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) in response to an outbreak of Mpox. FDA has issued the Authorization for Labcorp Monkeypox PCR (Polymerase Chain Reaction) Test Home Collection Kit as requested by Laboratory Corporation of America. The Authorization contains, among other things, conditions on the emergency use of the authorized product. The Authorization follows the August 9, 2022, determination by the Secretary of Health and Human Services (HHS) that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves monkeypox virus. On the basis of such determination, the Secretary of HHS declared, on September 7, 2022, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, pursuant to the FD&C Act, subject to terms of any authorization issued under that section. The Authorization, which includes an explanation of the reasons for issuance, and can be accessed on FDA's website from the link indicated.
Glycine From India: Preliminary Results and Rescission, In Part, of Antidumping Duty Administrative Review; 2022-2023
Document Number: 2024-14713
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily finds that certain producers and/or exporters subject to this administrative review did not make sales of subject merchandise at less than normal value during the period of review (POR) June 1, 2022, through May 31, 2023. Interested parties are invited to comment on these preliminary results.
Raw Honey From Brazil: Preliminary Results and Partial Rescission of Antidumping Duty Administrative Review; 2021-2023
Document Number: 2024-14712
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily finds that raw honey from Brazil was sold in the United States at below normal value (NV) during the period of review (POR) November 23, 2021, through May 31, 2023. We are also rescinding the review with respect to certain companies that had no entries of the subject merchandise during the POR. We invite interested parties to comment on these preliminary results.
Environmental Impact Statements; Notice of Availability
Document Number: 2024-14711
Type: Notice
Date: 2024-07-05
Agency: Environmental Protection Agency
Agency Information Collection Activities; Online Eastern Population Sandhill Crane Survey Data Entry Portal
Document Number: 2024-14710
Type: Notice
Date: 2024-07-05
Agency: Fish and Wildlife Service, Department of the Interior
In accordance with the Paperwork Reduction Act of 1995, we, the U.S. Fish and Wildlife Service (Service), are proposing to renew information collection without change.
Notice of Final Federal Agency Actions on Proposed Transportation Project in Delaware
Document Number: 2024-14709
Type: Notice
Date: 2024-07-05
Agency: Federal Highway Administration, Department of Transportation
This notice announces action taken by FHWA and other Federal agencies that are final. The actions relate to the Wilmington Riverfront Transportation Infrastructure Project (Project) proposed by the City of Wilmington, consisting of 0.5 mile of City grid network in City of Wilmington, New Castle County, Delaware. The actions grant licenses, permits, or approvals for the Project. The Revised Environmental Assessment (EA), Finding of No Significant Impact (FONSI) under the National Environmental Policy Act (NEPA), and other documents in the Project file provide details on the Project and FHWA's actions.
Prohibition Against Certain Flights in the Kabul Flight Information Region (FIR) (OAKX)
Document Number: 2024-14708
Type: Rule
Date: 2024-07-05
Agency: Federal Aviation Administration, Department of Transportation
The Federal Aviation Administration (FAA) is issuing this final rule to permit all: U.S. air carriers; U.S. commercial operators; persons exercising the privileges of an airman certificate issued by the FAA, except when such persons are operating U.S.-registered aircraft for a foreign air carrier; and operators of U.S.-registered civil aircraft, except when the operator of such aircraft is a foreign air carrier, to operate transiting overflights of the Kabul Flight Information Region (FIR) (OAKX) on jet routes P500-G500 at altitudes at and above Flight Level (FL) 300, subject to the approval of, and in accordance with the conditions established by, the appropriate authorities of Afghanistan. The FAA became aware that certain U.S. operators were having difficulty using jet routes P500-G500 in the Kabul FIR (OAKX) at altitudes at and above FL320 due to aircraft performance issues under certain meteorological conditions. After consideration of Afghanistan's practice of publishing Notices to Air Missions (NOTAMs) regarding overflights on these jet routes, the lack of any reported security incidents posing safety-of-flight risks to civil aircraft overflights on these jet routes since the FAA issued this Special Federal Aviation Regulation (SFAR) in July 2023 or while the FAA flight prohibition NOTAM that preceded it was in effect, and the very brief period of time U.S. civil aviation overflights on these jet routes would be in the Kabul FIR (OAKX), the FAA has determined transiting U.S. civil aviation overflights operating on jet routes P500-G500 in the Kabul FIR (OAKX) at altitudes at and above FL300 present a low risk. The FAA continues to prohibit U.S. civil aviation operations in the remainder of the Kabul FIR (OAKX) at altitudes below FL320 due to hazards to persons and aircraft engaged in operations at those altitudes due to the risk posed by violent extremist and militant activity and the lack of adequate risk mitigation capabilities to counter such activity.
Airport Terminal Program; FY 2025 Funding Opportunity
Document Number: 2024-14707
Type: Notice
Date: 2024-07-05
Agency: Federal Aviation Administration, Department of Transportation
Reader Aids
Document Number: FR-2024-07-05-ReaderAids
Type: Reader Aids
Date: 2024-07-05
Sunshine Act Meetings
Document Number: 2024-14948
Type: Notice
Date: 2024-07-05
Agency: Commodity Futures Trading Commission, Agencies and Commissions
Sunshine Act Meeting Notice
Document Number: 2024-14935
Type: Notice
Date: 2024-07-05
Agency: Commission on Civil Rights
Sunshine Act Meetings
Document Number: 2024-14820
Type: Notice
Date: 2024-07-05
Agency: Farm Credit Administration, Agencies and Commissions
Initiation of Antidumping and Countervailing Duty Administrative Reviews
Document Number: 2024-14771
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) has received requests to conduct administrative reviews of various antidumping duty (AD) and countervailing duty (CVD) orders with May anniversary dates. In accordance with Commerce's regulations, we are initiating those administrative reviews.
Presidential Declaration Amendment of a Major Disaster for Public Assistance Only for the State of Kansas
Document Number: 2024-14770
Type: Notice
Date: 2024-07-05
Agency: Small Business Administration, Agencies and Commissions
This is an amendment of the Presidential declaration of a major disaster for Public Assistance Only for the State of Kansas (FEMA-4774-DR), dated 04/28/2024. Incident: Severe Winter Storm. Incident Period: 01/08/2024 through 01/16/2024.
Privacy Act of 1974; System of Records
Document Number: 2024-14768
Type: Notice
Date: 2024-07-05
Agency: Department of Homeland Security
In accordance with the Privacy Act of 1974, the Department of Homeland Security (DHS) proposes to modify and reissue a current DHS system of records titled, "DHS/U.S. Immigration and Customs Enforcement (ICE)-011 Criminal Arrest Records and Immigration Enforcement Records (CARIER) System of Records." DHS/ICE collects, uses, and maintains CARIER records to support the identification, apprehension, and removal of aliens (a term defined in law but used hereinafter as "non- citizens") unlawfully entering or present in the United States in violation of the Immigration and Nationality Act (INA), including fugitive non-citizens. DHS/ICE also uses CARIER to support the identification and arrest of individuals (both citizens and non- citizens) who commit violations of federal laws enforced by DHS. DHS/ ICE is reissuing this system of records notice to update the purpose of the system, add new categories of individuals, add new categories of records, and modify, remove, and propose new routine uses. Additionally, this notice includes non-substantive changes to simplify the formatting and text of the previously published notice. This modified system will be included in the Department's inventory of record systems.
Glycine From India: Preliminary Results and Partial Rescission of the Countervailing Duty Administrative Review; 2022
Document Number: 2024-14766
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily determines that countervailable subsidies are being provided to Kumar Industries, India (Kumar), a producer and exporter of glycine from India during the period of review (POR) January 1, 2022, through December 31, 2022. Interested parties are invited to comment on these preliminary results.
Prestressed Concrete Steel Wire Strand From Spain: Preliminary Results of Antidumping Duty Administrative Review; 2022-2023
Document Number: 2024-14765
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily determines that the producer/exporter subject to this administrative review made sales of subject merchandise at prices below normal value (NV) during the period of review (POR), June 1, 2022, through May 31, 2023. We invite interested parties to comment on these preliminary results.
Certain Cold-Drawn Mechanical Tubing of Carbon and Alloy Steel From India: Preliminary Results of Antidumping Duty Administrative Review; 2022-2023
Document Number: 2024-14764
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) is conducting an administrative review of the antidumping duty order on certain cold- drawn mechanical tubing of carbon and alloy steel (cold-drawn mechanical tubing) from India for the period of review (POR) June 1, 2022, through May 31, 2023. Commerce preliminarily finds that Goodluck India Limited (Goodluck) and Tube Products of India, Ltd., a unit of Tube Investments of India Limited (TII) made sales of subject merchandise at prices below normal value (NV) during the POR. We invite interested parties to comment on these preliminary results.
Crystalline Silicon Photovoltaic Cells, Whether or Not Assembled Into Modules, From the People's Republic of China: Final Results and Final Partial Rescission of Antidumping Duty Administrative Review; and Final Determination of No Shipments; 2021-2022
Document Number: 2024-14763
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) has determined that Shenzhen Sungold Solar Co., Ltd. (Sungold), and the companies to which Commerce granted separate rates, did not sell subject merchandise at prices below normal value (NV) during the period December 1, 2021, through November 30, 2022, the period of review (POR). Commerce also determined that certain companies do not qualify for a separate rate, and that it is appropriate to rescind this review with respect to certain companies that did not ship subject merchandise during the POR.
Raw Honey From the Socialist Republic of Vietnam: Preliminary Results of Antidumping Duty Administrative Review; 2021-2023
Document Number: 2024-14762
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, International Trade Administration
The U.S. Department of Commerce (Commerce) preliminarily determines that Ban Me Thout Honeybee Joint Stock Company (BMT), Daklak Honeybee Joint Stock Company (DakHoney), and 13 non-individually examined and separate-rate eligible exporters of raw honey from the Socialist Republic of Vietnam (Vietnam) sold subject merchandise to the United States at less than normal value (NV) during the period of review (POR) August 25, 2021, through May 31, 2023.
Interest Rate Paid on Cash Deposited To Secure U.S. Immigration and Customs Enforcement Immigration Bonds
Document Number: 2024-14759
Type: Notice
Date: 2024-07-05
Agency: Department of the Treasury
For the period beginning July 1, 2024, and ending on September 30, 2024, the U.S. Immigration and Customs Enforcement Immigration Bond interest rate is 3 per centum per annum.
Draft Environmental Assessment and Proposed Habitat Conservation Plan; Receipt of an Application for an Amended Incidental Take Permit, Cardinal Point Wind Project, McDonough and Warren Counties, Illinois
Document Number: 2024-14757
Type: Notice
Date: 2024-07-05
Agency: Fish and Wildlife Service, Department of the Interior
We, the U.S. Fish and Wildlife Service (Service), have received an application from Cardinal Point Wind Farm, LLC (applicant), to amend its existing incidental take permit (ITP) under the Endangered Species Act, for its Cardinal Point Wind Project (project). The applicant requests that the ITP be amended to include an increased take authorization for the tricolored bat. We request public comment on the application, which includes the applicant's revised HCP, and the Service's draft supplemental environmental assessment, prepared pursuant to the National Environmental Policy Act. The Service provides this notice to seek comments from the public and Federal, Tribal, State, and local governments.
Foreign Endangered Species; Receipt of Permit Applications
Document Number: 2024-14755
Type: Notice
Date: 2024-07-05
Agency: Fish and Wildlife Service, Department of the Interior
We, the U.S. Fish and Wildlife Service, invite the public to comment on applications to conduct certain activities with foreign species that are listed as endangered under the Endangered Species Act (ESA). With some exceptions, the ESA prohibits activities with listed species unless Federal authorization is issued that allows such activities. The ESA also requires that we invite public comment before issuing permits for any activity otherwise prohibited by the ESA with respect to any endangered species.
Information Collection; General Services Administration Acquisition Regulation; Contractor Qualifications and Financial Information, GSA Form 527
Document Number: 2024-14754
Type: Notice
Date: 2024-07-05
Agency: General Services Administration, Agencies and Commissions
In accordance with the Paperwork Reduction Act of 1995, and the Office of Management and Budget (OMB) regulations, GSA invites the public to comment on a request to review and approve an extension of a previously approved information collection requirement regarding contractor qualifications and financial information.
Presidential Declaration Amendment of a Major Disaster for Public Assistance Only for the State of Florida
Document Number: 2024-14753
Type: Notice
Date: 2024-07-05
Agency: Small Business Administration, Agencies and Commissions
This is an amendment of the Presidential declaration of a major disaster for Public Assistance Only for the State of Florida (FEMA-4794-DR), dated 06/17/2024. Incident: Severe Storms, Straight-line Winds, and Tornadoes. Incident Period: 05/10/2024.
Extension of the Application Deadline: The REACH Lark Galloway-Gilliam Award for Advancing Health Equity Challenge (REACH Lark Award Challenge)
Document Number: 2024-14727
Type: Notice
Date: 2024-07-05
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
On April 25, 2024, the Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), published in the Federal Register a notice announcing the 2024 Racial and Ethnic Approaches to Community Health (REACH) Lark Galloway-Gilliam for Advancing Health Equity Award Challenge (REACH Lark Award Challenge). The CDC established a deadline date of June 21, 2024, for the transmittal of applications. This notice extends the deadline date for applications through July 12, 2024.
Arts Advisory Panel Meetings
Document Number: 2024-14726
Type: Notice
Date: 2024-07-05
Agency: National Foundation on the Arts and the Humanities, Agencies and Commissions, National Endowment for the Arts
Pursuant to the Federal Advisory Committee Act, as amended, notice is hereby given that 9 meetings of the Arts Advisory Panel to the National Council on the Arts will be held by teleconference or videoconference.
Submission for OMB Review; Novation and Change-of-Name Agreements
Document Number: 2024-14725
Type: Notice
Date: 2024-07-05
Agency: Department of Defense, General Services Administration, Agencies and Commissions, National Aeronautics and Space Administration
Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division has submitted to the Office of Management and Budget (OMB) a request to review and approve an extension of a previously approved information collection requirement regarding novation and change-of-name agreements.
Final Environmental Impact Statement for the Barred Owl Management Strategy; Washington, Oregon, and California
Document Number: 2024-14724
Type: Notice
Date: 2024-07-05
Agency: Fish and Wildlife Service, Department of the Interior
The U.S. Fish and Wildlife Service (Service) developed a proposed barred owl management strategy (strategy) to address the threat that the nonnative and invasive barred owl (Strix varia) poses to two native western owl subspeciesthe northern spotted owl (Strix occidentalis caurina) and the California spotted owl (Strix occidentalis occidentalis). In accordance with the National Environmental Policy Act, this notice announces the availability of a final environmental impact statement (FEIS) evaluating the impacts on the human environment related to the proposed management strategy and associated take of barred owls, which is prohibited under the Migratory Bird Treaty Act unless authorized by the Service by permit or regulation. With this notice, we also make available the revised proposed management strategy.
Determination of Regulatory Review Period for Purposes of Patent Extension; RYSTIGGO
Document Number: 2024-14723
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for RYSTIGGO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
2030 Census Advisory Committee
Document Number: 2024-14721
Type: Notice
Date: 2024-07-05
Agency: Census Bureau, Department of Commerce
The Census Bureau is giving notice of a virtual meeting of the 2030 Census Advisory Committee (2030 CAC or Committee). The Committee will assist the Census Bureau in devising strategies to increase awareness of and participation in the next decennial census, reduce barriers to response, and enhance the public's trust and willingness to respond. Last minute changes to the schedule are possible, which could prevent giving advance public notice of schedule adjustments.
Determination of Regulatory Review Period for Purposes of Patent Extension; VABYSMO
Document Number: 2024-14720
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for VABYSMO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Authorization of Emergency Use of an In Vitro Diagnostic Device in Response to an Outbreak of Mpox; Availability
Document Number: 2024-14719
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) in response to an outbreak of Mpox. FDA has issued an Authorization for an in vitro diagnostic device, Non-variola Orthopoxvirus Real-time PCR Primer and Probe Set as requested by the Centers for Disease Control and Prevention (CDC). The Authorization contains, among other things, conditions on the emergency use of the authorized product. The Authorization follows the August 9, 2022, determination by the Secretary of Health and Human Services (HHS) that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves monkeypox virus. On the basis of such determination, the Secretary of HHS declared, on September 7, 2022, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, pursuant to the FD&C Act, subject to terms of any authorization issued under that section. The Authorization, which includes an explanation of the reasons for issuance, and can be accessed on FDA's website from the link indicated in Section III. Authorization.
Economic Growth Regulatory Relief and Consumer Protection Act: Implementation of National Standards for the Physical Inspection of Real Estate (NSPIRE); Extension of NSPIRE Compliance Date for HCV, PBV and Section 8 Moderate Rehab and CPD Programs
Document Number: 2024-14718
Type: Notice
Date: 2024-07-05
Agency: Department of Housing and Urban Development
This notice further extends the compliance date for HUD's National Standards for the Physical Inspection of Real Estate (NSPIRE) final rule for the Housing Choice Voucher (HCV), Project Based Voucher (PBV) and Section 8 Moderate Rehabilitation programs, and for the HOME Investment Partnerships Program (HOME) and Housing Trust Fund (HTF), Housing Opportunities for Persons With AIDS (HOPWA), Emergency Solution Grants (ESG) and Continuum of Care (COC) programs ("CPD programs"), until October 1, 2025. HUD is taking this action to allow Public Housing Authorities (PHAs), jurisdictions, participants, recipients, and grantees additional time to implement HUD's NSPIRE standards. This is the second extension of this compliance date.
M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines; International Council for Harmonisation; Draft Guidance for Industry; Availability
Document Number: 2024-14717
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines." The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The draft guidance outlines general principles on planning, designing, and analyzing observational (noninterventional) pharmacoepidemiological studies that utilize fit-for-purpose data for safety assessment of medicines (drugs, vaccines, and other biological products). The draft guidance includes recommendations and high-level best practices for the conduct of these studies. The draft guidance is intended to streamline the development and regulatory assessment of postmarketing pharmacoepidemiological safety studies that include Real-World Data. This guidance also seeks to improve the ability of the study protocol and/or results to be accepted across health authorities and support decision making in response to study results.
Taking and Importing of Marine Mammals
Document Number: 2024-14739
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, National Oceanic and Atmospheric Administration
The NMFS Assistant Administrator (Assistant Administrator) has completed an affirmative finding annual renewal for the Governments of Ecuador, El Salvador, Guatemala, Mexico, Peru, and Spain (referred to hereafter as "The Nations") under the portions of the Marine Mammal Protection Act (MMPA) related to the eastern tropical Pacific Ocean (ETP) tuna purse seine fishery and the importation of yellowfin tuna from nations participating in this fishery. These affirmative findings will continue to allow the importation into the United States of yellowfin tuna and yellowfin tuna products harvested in the ETP for 1 year, in compliance with the Agreement on the International Dolphin Conservation Program (AIDCP), by purse seine vessels operating under The Nations' jurisdiction or exported from The Nations. NMFS bases the affirmative finding annual renewals on reviews of documentary evidence submitted by the Governments of The Nations and of information obtained from the Inter-American Tropical Tuna Commission (IATTC).
Taking and Importing of Marine Mammals
Document Number: 2024-14738
Type: Notice
Date: 2024-07-05
Agency: Department of Commerce, National Oceanic and Atmospheric Administration
The NMFS Assistant Administrator (Assistant Administrator) has issued a new 5-year affirmative finding for the Government of Colombia under the portions of the Marine Mammal Protection Act (MMPA) related to the eastern tropical Pacific Ocean (ETP) tuna purse seine fishery and the importation of yellowfin tuna from nations participating in this fishery. This affirmative finding will allow the importation into the United States of yellowfin tuna and yellowfin tuna products harvested in the ETP, in compliance with the Agreement on the International Dolphin Conservation Program (AIDCP), by purse seine vessels operating under Colombia's jurisdiction or exported from Colombia. NMFS bases the affirmative finding determination on reviews of documentary evidence submitted by the Government of Colombia and of information obtained from the Inter-American Tropical Tuna Commission (IATTC).
Procurement List; Proposed Deletions
Document Number: 2024-14736
Type: Notice
Date: 2024-07-05
Agency: Committee for Purchase From People Who Are Blind or Severely Disabled, Agencies and Commissions
The Committee is proposing to delete service(s) to the Procurement List that were furnished by nonprofit agencies employing persons who are blind or have other severe disabilities.
Qualification of Drivers; Exemption Applications; Hearing
Document Number: 2024-14735
Type: Notice
Date: 2024-07-05
Agency: Federal Motor Carrier Safety Administration, Department of Transportation
FMCSA announces its decision to exempt 10 individuals from the hearing requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) to operate a commercial motor vehicle (CMV) in interstate commerce. The exemptions enable these hard of hearing and deaf individuals to operate CMVs in interstate commerce.
Procurement List; Additions
Document Number: 2024-14734
Type: Notice
Date: 2024-07-05
Agency: Committee for Purchase From People Who Are Blind or Severely Disabled, Agencies and Commissions
This action adds service(s) to the Procurement List that will be furnished by nonprofit agencies employing persons who are blind or have other severe disabilities.
Determination of Regulatory Review Period for Purposes of Patent Extension; DAXXIFY
Document Number: 2024-14732
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for DAXXIFY and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2024-14730
Type: Notice
Date: 2024-07-05
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Determination of Regulatory Review Period for Purposes of Patent Extension; ENJAYMO
Document Number: 2024-14729
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for ENJAYMO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Determination of Regulatory Review Period for Purposes of Patent Extension; LUNSUMIO
Document Number: 2024-14728
Type: Notice
Date: 2024-07-05
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for LUNSUMIO and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.